Cresset Asset Management, LLC Macrogenics Inc Transaction History
Cresset Asset Management, LLC
- $19.6 Billion
- Q2 2025
A detailed history of Cresset Asset Management, LLC transactions in Macrogenics Inc stock. As of the latest transaction made, Cresset Asset Management, LLC holds 26,720 shares of MGNX stock, worth $34,736. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,720
Previous 17,548
52.27%
Holding current value
$34,736
Previous $22,000
45.45%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding MGNX
# of Institutions
118Shares Held
52.5MCall Options Held
55.3KPut Options Held
35.9K-
Bellevue Group Ag Kuesnacht, V89.92MShares$12.9 Million0.27% of portfolio
-
Armistice Capital, LLC New York, NY5.96MShares$7.75 Million0.13% of portfolio
-
Black Rock Inc. New York, NY5.4MShares$7.02 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.22MShares$5.49 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.25MShares$4.23 Million0.02% of portfolio
About MACROGENICS INC
- Ticker MGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,458,800
- Market Cap $79.9M
- Description
- MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...